OVP Venture Partners

OVP Venture Partners, established in 1983, is a Seattle-based venture capital firm with an additional office in Portland, Oregon. The company specializes in early-stage investments, primarily in the biotech, clean-tech, and technology sectors across the United States. OVP is known for its Entrepreneurs Fund, which brings together leading entrepreneurs from the Pacific Northwest to co-invest in projects alongside the firm, providing deal flow, contacts, and seasoned insights. The firm has a proven track record of navigating various market cycles and has successfully raised and managed multiple funds since its inception.

Bill Funcannon

Controller, Managing Director and CFO

Gerry Langeler

Managing Director

Chad Waite

Managing Director

118 past transactions

Group14 Technologies

Series B in 2020
Group14 Technologies, Inc. is a leading manufacturer and supplier of advanced silicon battery technology, specializing in engineered carbon materials for energy storage solutions including electric vehicles and consumer electronics. Founded in 2015 and headquartered in Woodinville, Washington, the company collaborates with clients representing 95% of global battery production. Group14 develops innovative battery materials that enhance energy performance in lithium-ion systems, providing clients with significantly increased lithium capacity while ensuring safety and longevity. The company operates a joint venture in South Korea and is expanding its manufacturing capabilities worldwide to meet the growing demand for silicon battery materials, aiming to enable a future where all rechargeable devices are powered by advanced battery technology.

Group14 Technologies

Series A in 2019
Group14 Technologies, Inc. is a leading manufacturer and supplier of advanced silicon battery technology, specializing in engineered carbon materials for energy storage solutions including electric vehicles and consumer electronics. Founded in 2015 and headquartered in Woodinville, Washington, the company collaborates with clients representing 95% of global battery production. Group14 develops innovative battery materials that enhance energy performance in lithium-ion systems, providing clients with significantly increased lithium capacity while ensuring safety and longevity. The company operates a joint venture in South Korea and is expanding its manufacturing capabilities worldwide to meet the growing demand for silicon battery materials, aiming to enable a future where all rechargeable devices are powered by advanced battery technology.

Verdezyne

Venture Round in 2014
Verdezyne is a private company specializing in synthetic biology, focusing on the production of chemicals from renewable sources. The company leverages its expertise in biological science and proprietary computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. Through this innovative approach, Verdezyne aims to optimize commercial fermentation processes, allowing for the creation of sustainable alternatives to petrochemicals. Its platform combines advanced biological techniques with proven manufacturing technologies, enabling the production of a wide range of chemical building blocks and additives used in everyday products. By reducing dependence on oil, Verdezyne provides cost-effective and environmentally friendly solutions in the chemical industry.

Adapx

Venture Round in 2013
Adapx, Inc. is a technology company that specializes in user interface software solutions designed to enhance data capture and operational efficiency for businesses and government agencies. Its flagship product, Capturx, seamlessly converts natural speech, sketches, and handwriting into structured data, streamlining workflows and minimizing the need for manual data transcription. Capturx offers various applications, including integrations for Microsoft Office, SharePoint, and ArcGIS, along with mobile solutions for data collection. The company caters to diverse sectors, including manufacturing, defense, health, and utilities, and provides additional services such as mobile workflow analysis and design optimization. Founded in 1999 and based in Seattle, Washington, Adapx has established strategic partnerships with notable organizations like Microsoft and ESRI, enhancing its capabilities and reach in the market.

Aggregate Knowledge

Venture Round in 2013
Aggregate Knowledge is a media intelligence company that specializes in providing advertisers and agencies with a comprehensive platform to identify and reach high-performing customers. Its patented media intelligence platform integrates both media and audience data, allowing marketers to optimize their advertising strategies effectively. By delivering real-time personalization and audience-centric display optimization services, Aggregate Knowledge enables clients to execute tailored advertising campaigns that enhance media spend efficiency, increase reach, and drive higher sales. The company's focus on combining data management solutions with actionable insights positions it as a pivotal player in the advertising technology landscape.

Aggregate Knowledge

Series E in 2013
Aggregate Knowledge is a media intelligence company that specializes in providing advertisers and agencies with a comprehensive platform to identify and reach high-performing customers. Its patented media intelligence platform integrates both media and audience data, allowing marketers to optimize their advertising strategies effectively. By delivering real-time personalization and audience-centric display optimization services, Aggregate Knowledge enables clients to execute tailored advertising campaigns that enhance media spend efficiency, increase reach, and drive higher sales. The company's focus on combining data management solutions with actionable insights positions it as a pivotal player in the advertising technology landscape.

EnerG2

Venture Round in 2013
EnerG2, Inc. is a manufacturer of engineered carbon materials based in Seattle, Washington, with an additional facility in Albany, Oregon. Founded in 2003, the company specializes in producing advanced nano-structured carbon materials tailored for energy storage applications. EnerG2's proprietary manufacturing technologies enable the development of high-performance materials that exceed the capabilities of naturally occurring carbons. These materials are designed to enhance power density and cycle life in a range of energy storage devices, including ultracapacitors, lead-acid batteries, and lithium-ion batteries. By focusing on customized electrode materials, EnerG2 aims to improve charge acceptance and device longevity, thereby advancing the efficiency and effectiveness of energy storage solutions.

NanoString Technologies

Series E in 2012
NanoString Technologies, Inc. is a life science company that specializes in providing innovative tools for translational research and molecular diagnostics globally. Founded in 2003 and headquartered in Seattle, Washington, the company developed a unique digital molecular barcoding technology for various applications in basic research and clinical diagnostics. Its flagship product, the nCounter Analysis System, consists of automated systems for sample preparation and data collection, allowing for the simultaneous profiling of numerous genes and proteins from single tissue samples. Additionally, NanoString offers the GeoMx Digital Spatial Profiler, which enhances spatial genomics research. The company also provides a range of services, including custom assay design, data analysis software, and molecular diagnostic test kits, such as Prosigna for breast cancer prognosis. Collaborations with major pharmaceutical companies and research institutions further bolster its position in advancing genomic and proteomic research.

Adapx

Venture Round in 2012
Adapx, Inc. is a technology company that specializes in user interface software solutions designed to enhance data capture and operational efficiency for businesses and government agencies. Its flagship product, Capturx, seamlessly converts natural speech, sketches, and handwriting into structured data, streamlining workflows and minimizing the need for manual data transcription. Capturx offers various applications, including integrations for Microsoft Office, SharePoint, and ArcGIS, along with mobile solutions for data collection. The company caters to diverse sectors, including manufacturing, defense, health, and utilities, and provides additional services such as mobile workflow analysis and design optimization. Founded in 1999 and based in Seattle, Washington, Adapx has established strategic partnerships with notable organizations like Microsoft and ESRI, enhancing its capabilities and reach in the market.

Symform

Series B in 2012
Symform is a provider of cost-effective storage and backup services aimed at addressing large-scale distributed data management challenges. The company offers the Symform Cooperative Storage Cloud, a solution that integrates disaster recovery, data security, and distributed networking by leveraging unused server space from its members. In this model, users contribute local storage equal to their consumption in the cloud, thereby creating a collaborative storage network. Symform manages the day-to-day operations of network security and administration, allowing members to benefit from unlimited online storage without the need for traditional backup tapes or data center services.

DataSphere Technologies

Series D in 2012
DataSphere Technologies is a developer of an advertising platform aimed at enhancing business success by facilitating connections between business owners and customers. The company focuses on making mobile marketing accessible, affordable, and user-friendly for a diverse clientele, including small local businesses and larger brands with multiple locations. By providing Web technology and a dedicated ad sales team, DataSphere enables existing media companies to generate user engagement at the neighborhood level and effectively monetize their offerings. This approach allows businesses to differentiate their brands and attract interest from local consumers.

GenoLogics

Series D in 2012
GenoLogics, Inc. is a software development company that specializes in laboratory information management systems to enhance the diagnosis and treatment of diseases. Founded in 2002 and headquartered in Victoria, Canada, with an additional office in Redwood City, California, GenoLogics offers its BaseSpace Clarity LIMS, which supports research and clinical laboratories by tracking samples throughout the testing process. This platform facilitates improved accuracy, cost reduction, and quality maintenance. The company focuses on translational medicine and systems biology, providing solutions that enable integration across multiple laboratories and enhance biomedical research efforts. As of August 2015, GenoLogics operates as a subsidiary of Illumina Inc.

Symform

Venture Round in 2012
Symform is a provider of cost-effective storage and backup services aimed at addressing large-scale distributed data management challenges. The company offers the Symform Cooperative Storage Cloud, a solution that integrates disaster recovery, data security, and distributed networking by leveraging unused server space from its members. In this model, users contribute local storage equal to their consumption in the cloud, thereby creating a collaborative storage network. Symform manages the day-to-day operations of network security and administration, allowing members to benefit from unlimited online storage without the need for traditional backup tapes or data center services.

Groove Biopharma

Series B in 2011
Groove Biopharma focuses on the generation of novel microRNA (miRNA) therapeutics with improved properties, including higher potency and enhanced pharmacodynamic activity. Endogenous microRNAs (miRNAs) are involved in extensive regulatory networks for many target genes and pathways. Groove Biopharma’s core technology addresses a new avenue of nucleotide therapeutic drug discovery via modulation of cellular miRNA. Using exclusive technology, Groove Biopharma is generating a series of lead candidates with the potential to be best-in-class therapeutics. By incorporating proprietary structural modifications into miRNA therapeutics, the Groove Biopharma technology platform presents promising potential for treating a wide range of diseases, including cancer, fibrosis, and infectious disease.

RedSeal

Venture Round in 2011
RedSeal, Inc. specializes in cybersecurity analytics solutions aimed at enhancing the digital resilience of organizations and government agencies globally. Founded in 2004 and based in San Jose, California, RedSeal's platform creates detailed network models and assesses security risks, allowing users to prioritize actions for remediation. By identifying potential attack paths to critical assets, the solution helps organizations allocate their limited security resources effectively, improve incident response times, and maintain comprehensive network visibility. RedSeal's offerings support compliance with various industry regulations and standards, while its technology integrates seamlessly with leading security tools and infrastructure providers. The company serves a diverse client base, including major financial institutions, retail companies, and U.S. federal agencies. RedSeal has established partnerships with top network infrastructure suppliers and is backed by several notable venture capital firms.

NanoString Technologies

Series D in 2011
NanoString Technologies, Inc. is a life science company that specializes in providing innovative tools for translational research and molecular diagnostics globally. Founded in 2003 and headquartered in Seattle, Washington, the company developed a unique digital molecular barcoding technology for various applications in basic research and clinical diagnostics. Its flagship product, the nCounter Analysis System, consists of automated systems for sample preparation and data collection, allowing for the simultaneous profiling of numerous genes and proteins from single tissue samples. Additionally, NanoString offers the GeoMx Digital Spatial Profiler, which enhances spatial genomics research. The company also provides a range of services, including custom assay design, data analysis software, and molecular diagnostic test kits, such as Prosigna for breast cancer prognosis. Collaborations with major pharmaceutical companies and research institutions further bolster its position in advancing genomic and proteomic research.

Oncofactor

Series A in 2011
Oncofactor is a Seattle, Washington-based developer of cancer therapeutics that disrupt signaling pathways between tumors and the immune system.

PrecisionDemand

Series C in 2011
PrecisionDemand is an early-stage company headquartered in Seattle with a presence in New York, specializing in television media agency services. The company employs advanced analytics to efficiently target advertisements towards clients' most promising prospects across various demographic and behavioral attributes. Their proprietary Buyometric targeting system enables precise TV audience targeting, reducing clients' cost-per-sale by over 25% while accurately predicting sales volumes through multiple channels with over 95% accuracy. PrecisionDemand offers comprehensive campaign tracking, analysis, and optimization services, providing clients with valuable insights into marketing effectiveness and operational efficiency.

Adapx

Venture Round in 2011
Adapx, Inc. is a technology company that specializes in user interface software solutions designed to enhance data capture and operational efficiency for businesses and government agencies. Its flagship product, Capturx, seamlessly converts natural speech, sketches, and handwriting into structured data, streamlining workflows and minimizing the need for manual data transcription. Capturx offers various applications, including integrations for Microsoft Office, SharePoint, and ArcGIS, along with mobile solutions for data collection. The company caters to diverse sectors, including manufacturing, defense, health, and utilities, and provides additional services such as mobile workflow analysis and design optimization. Founded in 1999 and based in Seattle, Washington, Adapx has established strategic partnerships with notable organizations like Microsoft and ESRI, enhancing its capabilities and reach in the market.

Verdezyne

Venture Round in 2011
Verdezyne is a private company specializing in synthetic biology, focusing on the production of chemicals from renewable sources. The company leverages its expertise in biological science and proprietary computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. Through this innovative approach, Verdezyne aims to optimize commercial fermentation processes, allowing for the creation of sustainable alternatives to petrochemicals. Its platform combines advanced biological techniques with proven manufacturing technologies, enabling the production of a wide range of chemical building blocks and additives used in everyday products. By reducing dependence on oil, Verdezyne provides cost-effective and environmentally friendly solutions in the chemical industry.

Fate Therapeutics

Series B in 2011
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing programmed cellular immunotherapies for cancer and immune disorders. The company specializes in NK- and T-cell immuno-oncology programs, with a diverse pipeline that includes candidates such as FT516 and FT596 for treating various hematologic malignancies, FT538 for acute myeloid leukemia and multiple myeloma, and FT500 for advanced solid tumors. Fate Therapeutics employs advanced techniques involving induced pluripotent stem cells (iPSCs) to create engineered product candidates, which are designed to be off-the-shelf solutions. The company has established strategic collaborations with notable partners, including Ono Pharmaceutical Co. Ltd. and Janssen Biotech, to enhance its research and development capabilities. Founded in 2007, Fate Therapeutics aims to leverage cutting-edge science to create innovative therapies that restore health by modulating the properties of stem cells.

Cradlepoint

Venture Round in 2011
CradlePoint, Inc. is a provider of secure cloud-managed networking solutions designed for the Distributed Enterprise, specializing in 3G, 4G, LTE, and 5G technologies. Founded in 2004 and headquartered in Boise, Idaho, the company offers a range of products including wireless routers, edge defense solutions, and the Cradlepoint NetCloud platform. This platform extends the capabilities of multi-function routers and IoT gateways with cloud-based management and software-defined networking services. CradlePoint’s solutions enable organizations to maintain connectivity and security across diverse environments, including branches, mobile workforces, and IoT networks. The company serves over 15,000 enterprise and government customers globally, including many of the world's top retailers and Fortune 100 companies. With additional offices in the UK, Australia, and Japan, CradlePoint's technology supports seamless and secure connections for critical sites, workforces, vehicles, and devices.

Acylin Therapeutics

Series A in 2011
Acylin Therapeutics is the first company focused on developing inhibitors of cellular acetylation, an enzymatic mechanism fundamental to the molecular pathology of cancer, metabolic disease, and neurodegeneration. Recent discoveries by Acylin founders and other investigators have revealed protein acetylation as a cellular signal transduction regulator potentially as ubiquitous and important as phosphorylation by kinase enzymes. The Company has developed a platform technology to design specific acyltransferase inhibitors based on crystal structures, novel medicinal chemical approaches, and mechanistic understanding. Acylin has prioritized the p300 and CBP histone acetyl transferases [HATs] for initial drug discovery.

Carbonflow

Series B in 2010
CarbonFlow is a company that specializes in developing carbon trading software aimed at reducing the cost and time required to create carbon credits. Founded in 2006, CarbonFlow enhances productivity by streamlining administrative processes and mitigating financial risks associated with managing Greenhouse Gas (GHG) offset projects. The company's suite of tools facilitates the delivery of certified carbon credits for buyers and sellers globally, leveraging web technology to expedite carbon reduction initiatives.

DataSphere Technologies

Series C in 2010
DataSphere Technologies is a developer of an advertising platform aimed at enhancing business success by facilitating connections between business owners and customers. The company focuses on making mobile marketing accessible, affordable, and user-friendly for a diverse clientele, including small local businesses and larger brands with multiple locations. By providing Web technology and a dedicated ad sales team, DataSphere enables existing media companies to generate user engagement at the neighborhood level and effectively monetize their offerings. This approach allows businesses to differentiate their brands and attract interest from local consumers.

Complete Genomics

Series E in 2010
Complete Genomics is a developer of advanced DNA sequencing technology focused on human genome sequencing and analysis. The company offers a comprehensive genomics analysis platform that integrates its proprietary sequencing technology with informatics and data management software. This combination allows Complete Genomics to deliver high-quality, affordable DNA sequencing services that facilitate large-scale research into the genetic mechanisms underlying drug responses and complex diseases. By providing ready-to-use genomic data, Complete Genomics aims to enhance the capabilities of researchers in the field of genomics and contribute to advancements in personalized medicine.

Symform

Venture Round in 2010
Symform is a provider of cost-effective storage and backup services aimed at addressing large-scale distributed data management challenges. The company offers the Symform Cooperative Storage Cloud, a solution that integrates disaster recovery, data security, and distributed networking by leveraging unused server space from its members. In this model, users contribute local storage equal to their consumption in the cloud, thereby creating a collaborative storage network. Symform manages the day-to-day operations of network security and administration, allowing members to benefit from unlimited online storage without the need for traditional backup tapes or data center services.

Tigo Energy

Series C in 2010
Tigo Energy, Inc. specializes in developing module-level power electronics and module optimizer technology for the solar industry. The company offers solar optimizers and comprehensive software solutions that include module-level monitoring for utility, commercial, and residential photovoltaic (PV) arrays, as well as a mobile application for solar management. Tigo Energy also provides communication solutions, such as gateways and a Maximizer Management Unit, which facilitate communication between optimizers and inverters. Its products cater to a diverse range of markets, including residential, commercial, utility, third-party finance, schools, and government sectors, and are distributed through various channels. Founded in 2007 and headquartered in Campbell, California, with an additional office in Tuscany, Italy, Tigo Energy operates globally across the United States, Europe, Japan, China, Australia, Brazil, and the Middle East. The company's focus is on enhancing safety, increasing energy yield, and reducing operating costs, ultimately improving the efficiency and reliability of solar installations.

Groove Biopharma

Series A in 2010
Groove Biopharma focuses on the generation of novel microRNA (miRNA) therapeutics with improved properties, including higher potency and enhanced pharmacodynamic activity. Endogenous microRNAs (miRNAs) are involved in extensive regulatory networks for many target genes and pathways. Groove Biopharma’s core technology addresses a new avenue of nucleotide therapeutic drug discovery via modulation of cellular miRNA. Using exclusive technology, Groove Biopharma is generating a series of lead candidates with the potential to be best-in-class therapeutics. By incorporating proprietary structural modifications into miRNA therapeutics, the Groove Biopharma technology platform presents promising potential for treating a wide range of diseases, including cancer, fibrosis, and infectious disease.

PrecisionDemand

Series B in 2010
PrecisionDemand is an early-stage company headquartered in Seattle with a presence in New York, specializing in television media agency services. The company employs advanced analytics to efficiently target advertisements towards clients' most promising prospects across various demographic and behavioral attributes. Their proprietary Buyometric targeting system enables precise TV audience targeting, reducing clients' cost-per-sale by over 25% while accurately predicting sales volumes through multiple channels with over 95% accuracy. PrecisionDemand offers comprehensive campaign tracking, analysis, and optimization services, providing clients with valuable insights into marketing effectiveness and operational efficiency.

Verdezyne

Venture Round in 2010
Verdezyne is a private company specializing in synthetic biology, focusing on the production of chemicals from renewable sources. The company leverages its expertise in biological science and proprietary computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. Through this innovative approach, Verdezyne aims to optimize commercial fermentation processes, allowing for the creation of sustainable alternatives to petrochemicals. Its platform combines advanced biological techniques with proven manufacturing technologies, enabling the production of a wide range of chemical building blocks and additives used in everyday products. By reducing dependence on oil, Verdezyne provides cost-effective and environmentally friendly solutions in the chemical industry.

Aggregate Knowledge

Series C in 2010
Aggregate Knowledge is a media intelligence company that specializes in providing advertisers and agencies with a comprehensive platform to identify and reach high-performing customers. Its patented media intelligence platform integrates both media and audience data, allowing marketers to optimize their advertising strategies effectively. By delivering real-time personalization and audience-centric display optimization services, Aggregate Knowledge enables clients to execute tailored advertising campaigns that enhance media spend efficiency, increase reach, and drive higher sales. The company's focus on combining data management solutions with actionable insights positions it as a pivotal player in the advertising technology landscape.

Fate Therapeutics

Series B in 2009
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing programmed cellular immunotherapies for cancer and immune disorders. The company specializes in NK- and T-cell immuno-oncology programs, with a diverse pipeline that includes candidates such as FT516 and FT596 for treating various hematologic malignancies, FT538 for acute myeloid leukemia and multiple myeloma, and FT500 for advanced solid tumors. Fate Therapeutics employs advanced techniques involving induced pluripotent stem cells (iPSCs) to create engineered product candidates, which are designed to be off-the-shelf solutions. The company has established strategic collaborations with notable partners, including Ono Pharmaceutical Co. Ltd. and Janssen Biotech, to enhance its research and development capabilities. Founded in 2007, Fate Therapeutics aims to leverage cutting-edge science to create innovative therapies that restore health by modulating the properties of stem cells.

Verdezyne

Venture Round in 2009
Verdezyne is a private company specializing in synthetic biology, focusing on the production of chemicals from renewable sources. The company leverages its expertise in biological science and proprietary computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. Through this innovative approach, Verdezyne aims to optimize commercial fermentation processes, allowing for the creation of sustainable alternatives to petrochemicals. Its platform combines advanced biological techniques with proven manufacturing technologies, enabling the production of a wide range of chemical building blocks and additives used in everyday products. By reducing dependence on oil, Verdezyne provides cost-effective and environmentally friendly solutions in the chemical industry.

RedSeal

Series C in 2009
RedSeal, Inc. specializes in cybersecurity analytics solutions aimed at enhancing the digital resilience of organizations and government agencies globally. Founded in 2004 and based in San Jose, California, RedSeal's platform creates detailed network models and assesses security risks, allowing users to prioritize actions for remediation. By identifying potential attack paths to critical assets, the solution helps organizations allocate their limited security resources effectively, improve incident response times, and maintain comprehensive network visibility. RedSeal's offerings support compliance with various industry regulations and standards, while its technology integrates seamlessly with leading security tools and infrastructure providers. The company serves a diverse client base, including major financial institutions, retail companies, and U.S. federal agencies. RedSeal has established partnerships with top network infrastructure suppliers and is backed by several notable venture capital firms.

PrecisionDemand

Series B in 2009
PrecisionDemand is an early-stage company headquartered in Seattle with a presence in New York, specializing in television media agency services. The company employs advanced analytics to efficiently target advertisements towards clients' most promising prospects across various demographic and behavioral attributes. Their proprietary Buyometric targeting system enables precise TV audience targeting, reducing clients' cost-per-sale by over 25% while accurately predicting sales volumes through multiple channels with over 95% accuracy. PrecisionDemand offers comprehensive campaign tracking, analysis, and optimization services, providing clients with valuable insights into marketing effectiveness and operational efficiency.

Complete Genomics

Series D in 2009
Complete Genomics is a developer of advanced DNA sequencing technology focused on human genome sequencing and analysis. The company offers a comprehensive genomics analysis platform that integrates its proprietary sequencing technology with informatics and data management software. This combination allows Complete Genomics to deliver high-quality, affordable DNA sequencing services that facilitate large-scale research into the genetic mechanisms underlying drug responses and complex diseases. By providing ready-to-use genomic data, Complete Genomics aims to enhance the capabilities of researchers in the field of genomics and contribute to advancements in personalized medicine.

Translarity

Series B in 2009
Translarity, headquartered in Silicon Valley, specializes in innovative semiconductor wafer testing solutions, focusing on advanced probe card markets. The company pioneers full-wafer testing with low cost, high performance, and short cycle times. In 2017, Translarity acquired BucklingBeam to expand its offerings, now providing a comprehensive suite of probe card solutions including full probe cards and vertical probe head solutions. Leveraging its proprietary Space Translator™ technology, Translarity addresses the rapid evolution in probe technologies. Led by an experienced management team and supported by strong financial investors, Translarity has recruited top industry talent to develop Wafer Translator™ technology, resulting in a robust IP portfolio with over 45 issued patents and more than 50 filed.

Novomer

Series B in 2009
Novomer is a materials company based in Waltham, Massachusetts, founded in 2004. The company specializes in developing high-performance green plastics, polymers, and other chemicals using proprietary catalytic technology. This technology enables the cost-effective transformation of carbon dioxide and other renewable materials into various industrial products. By combining traditional chemical feedstocks with carbon dioxide or carbon monoxide, Novomer aims to create sustainable chemicals and materials for diverse applications, contributing to efforts in mitigating global warming and climate change.

Limerick BioPharma

Series C in 2009
Limerick BioPharma focuses on the development of innovative pharmaceutical compounds aimed at enhancing patient care. The company specializes in creating adjunctive therapies that reduce toxic side effects on non-targeted organs and tissues while preserving or improving the efficacy of existing and investigational drugs. In addition to its adjunctive approaches, Limerick BioPharma is also engaged in developing novel monotherapy compounds specifically targeting metabolic diseases, including hypercholesteremia and hyperglycemia. The company employs advanced methods to simulate blood-tissue barrier activities both in vitro and in vivo, positioning itself as a leader in addressing challenges related to tissue-specific toxicity and solid organ transplantation.

Tigo Energy

Series B in 2009
Tigo Energy, Inc. specializes in developing module-level power electronics and module optimizer technology for the solar industry. The company offers solar optimizers and comprehensive software solutions that include module-level monitoring for utility, commercial, and residential photovoltaic (PV) arrays, as well as a mobile application for solar management. Tigo Energy also provides communication solutions, such as gateways and a Maximizer Management Unit, which facilitate communication between optimizers and inverters. Its products cater to a diverse range of markets, including residential, commercial, utility, third-party finance, schools, and government sectors, and are distributed through various channels. Founded in 2007 and headquartered in Campbell, California, with an additional office in Tuscany, Italy, Tigo Energy operates globally across the United States, Europe, Japan, China, Australia, Brazil, and the Middle East. The company's focus is on enhancing safety, increasing energy yield, and reducing operating costs, ultimately improving the efficiency and reliability of solar installations.

Symform

Series A in 2009
Symform is a provider of cost-effective storage and backup services aimed at addressing large-scale distributed data management challenges. The company offers the Symform Cooperative Storage Cloud, a solution that integrates disaster recovery, data security, and distributed networking by leveraging unused server space from its members. In this model, users contribute local storage equal to their consumption in the cloud, thereby creating a collaborative storage network. Symform manages the day-to-day operations of network security and administration, allowing members to benefit from unlimited online storage without the need for traditional backup tapes or data center services.

Adapx

Series B in 2009
Adapx, Inc. is a technology company that specializes in user interface software solutions designed to enhance data capture and operational efficiency for businesses and government agencies. Its flagship product, Capturx, seamlessly converts natural speech, sketches, and handwriting into structured data, streamlining workflows and minimizing the need for manual data transcription. Capturx offers various applications, including integrations for Microsoft Office, SharePoint, and ArcGIS, along with mobile solutions for data collection. The company caters to diverse sectors, including manufacturing, defense, health, and utilities, and provides additional services such as mobile workflow analysis and design optimization. Founded in 1999 and based in Seattle, Washington, Adapx has established strategic partnerships with notable organizations like Microsoft and ESRI, enhancing its capabilities and reach in the market.

GenoLogics

Series C in 2009
GenoLogics, Inc. is a software development company that specializes in laboratory information management systems to enhance the diagnosis and treatment of diseases. Founded in 2002 and headquartered in Victoria, Canada, with an additional office in Redwood City, California, GenoLogics offers its BaseSpace Clarity LIMS, which supports research and clinical laboratories by tracking samples throughout the testing process. This platform facilitates improved accuracy, cost reduction, and quality maintenance. The company focuses on translational medicine and systems biology, providing solutions that enable integration across multiple laboratories and enhance biomedical research efforts. As of August 2015, GenoLogics operates as a subsidiary of Illumina Inc.

Napera Networks

Series A in 2008
Napera Networks specializes in cloud-based active network management services tailored for small and medium-sized enterprises. The company aims to simplify IT management while reducing associated costs and complexities. Napera offers innovative products such as the Napera N24, which ensures gigabit-speed switched-network access for authorized users with secure devices, while restricting access for guests or devices that do not meet health standards. Additionally, the Napera N24S complements the N24 by providing 24 ports of gigabit Ethernet and options for fiber connections, enhancing overall network performance and security. Acquired by OPSWAT, Napera Networks continues to focus on delivering effective network and security management solutions.

EnerG2

Series A in 2008
EnerG2, Inc. is a manufacturer of engineered carbon materials based in Seattle, Washington, with an additional facility in Albany, Oregon. Founded in 2003, the company specializes in producing advanced nano-structured carbon materials tailored for energy storage applications. EnerG2's proprietary manufacturing technologies enable the development of high-performance materials that exceed the capabilities of naturally occurring carbons. These materials are designed to enhance power density and cycle life in a range of energy storage devices, including ultracapacitors, lead-acid batteries, and lithium-ion batteries. By focusing on customized electrode materials, EnerG2 aims to improve charge acceptance and device longevity, thereby advancing the efficiency and effectiveness of energy storage solutions.

Applied Identity

Series C in 2008
Applied Identity, Inc. offers identity aware network security solutions. It offers ID-Audit, which displays real-time and historical user and resource activity; ID-Unify that enables the management of user identities between disparate identity stores; ID-Enforce, an identity aware network enforcement solution; and ID-Mark, which enables collection of audit data. The company also provides audit and compliance, asset protection, network level user and group separation, and identity virtualization solutions. Its clients include financial services, government department and agencies, technology innovators, and educational institutions.

Carbonflow

Series A in 2008
CarbonFlow is a company that specializes in developing carbon trading software aimed at reducing the cost and time required to create carbon credits. Founded in 2006, CarbonFlow enhances productivity by streamlining administrative processes and mitigating financial risks associated with managing Greenhouse Gas (GHG) offset projects. The company's suite of tools facilitates the delivery of certified carbon credits for buyers and sellers globally, leveraging web technology to expedite carbon reduction initiatives.

DepotPoint

Series C in 2008
DepotPoint is a software company that specializes in the distressed property market, emphasizing transparency, efficiency, and intelligence in its solutions. Founded in 2005 and headquartered in Bellevue, Washington, DepotPoint develops web-based platforms tailored for the real estate foreclosure sector in the United States. Its primary offerings include the TrackPoint Platform, which enables users to manage property files throughout the default process, and ForeclosurePoint, a marketing platform designed to provide resources for real estate professionals and buyers dealing with distressed properties.

PrecisionDemand

Series A in 2008
PrecisionDemand is an early-stage company headquartered in Seattle with a presence in New York, specializing in television media agency services. The company employs advanced analytics to efficiently target advertisements towards clients' most promising prospects across various demographic and behavioral attributes. Their proprietary Buyometric targeting system enables precise TV audience targeting, reducing clients' cost-per-sale by over 25% while accurately predicting sales volumes through multiple channels with over 95% accuracy. PrecisionDemand offers comprehensive campaign tracking, analysis, and optimization services, providing clients with valuable insights into marketing effectiveness and operational efficiency.

Vantos

Series B in 2008
Vantos is a leading provider in the Enterprise Investigation Management market, offering comprehensive solutions for a range of workplace investigations, from minor misconduct to serious financial crimes. The company specializes in the automation and management of the investigation lifecycle through its flagship product, V-Flex. This platform includes analytics and visualization tools that help investigators identify trends and uncover root causes in data. Additionally, Vantos develops investigative playbooks that streamline the process for commonly occurring investigations, enabling organizations to effectively address their evolving investigation needs while minimizing costs.

Talyst

Series C in 2008
Talyst, founded in 2002, specializes in developing automated medication management systems aimed at enhancing patient safety across various healthcare environments. Initially focused on acute care hospital pharmacies, the company launched its flagship software platform, AutoPharm®, in 2003, which integrates medication storage, inventory management, ordering, barcoding, and clinical systems. Talyst's solutions are designed to improve workflow efficiency and patient safety not only in hospitals but also in long-term care facilities and correctional institutions, ensuring a comprehensive approach to medication management.

Tigo Energy

Series A in 2008
Tigo Energy, Inc. specializes in developing module-level power electronics and module optimizer technology for the solar industry. The company offers solar optimizers and comprehensive software solutions that include module-level monitoring for utility, commercial, and residential photovoltaic (PV) arrays, as well as a mobile application for solar management. Tigo Energy also provides communication solutions, such as gateways and a Maximizer Management Unit, which facilitate communication between optimizers and inverters. Its products cater to a diverse range of markets, including residential, commercial, utility, third-party finance, schools, and government sectors, and are distributed through various channels. Founded in 2007 and headquartered in Campbell, California, with an additional office in Tuscany, Italy, Tigo Energy operates globally across the United States, Europe, Japan, China, Australia, Brazil, and the Middle East. The company's focus is on enhancing safety, increasing energy yield, and reducing operating costs, ultimately improving the efficiency and reliability of solar installations.

Avenda Systems

Series B in 2008
Avenda Systems introduced the industry's first multi-function platform for network access control (NAC) and security that breaks through past deployment barriers found in early competitive solutions complexity, compatibility, compliance and cost. Avenda's flagship eTIPS solution is a scalable AAA platform that utilizes identity-based policies to manage access control, endpoint health and device authorization for wired, wireless and VPN networks. Users are granted differentiated privileges to control which network resources and applications they can access. Employee's roles, location, and the health of their computer can be used as determining factors. Visitors can be granted Internet only access if required. Partnerships with Cisco, Microsoft and top wireless vendors ensure that Avenda's solution fits into any network environment.

TZero Technologies

Series C in 2008
TZero Technologies designs and develops ultra wideband semiconductors for video distribution. The company offers wirelessly connects devices and ultra wideband chipsets, which connect audiovisual components, such as televisions, set-top boxes, and digital video recorders. It serves consumer electronics, service providers, and computer manufacturers. The company was founded in 2003 and is headquartered in Sunnyvale, California.

AdmitOne Security

Series C in 2008
AdmitOne Security, headquartered in Issaquah, Washington, specializes in providing Software as a Service (SaaS) solutions focused on authentication and anti-fraud measures. The company's technology leverages the unique typing characteristics of computer users to verify and secure access to computer systems, ensuring robust protection against unauthorized entry.

Max-Viz

Venture Round in 2008
Max-Viz is a specialized company focused exclusively on the design, development, and manufacturing of Enhanced Vision Systems for the aviation industry. It is the only organization dedicated to this niche, creating advanced infrared vision systems that enable aircraft operators to see clearly in challenging conditions such as fog, haze, smoke, and darkness. The company is driven by a team of passionate and experienced scientists and engineers, all committed to enhancing safety for both civilian and military aviation. Through its innovative technology, Max-Viz aims to improve visibility and operational efficiency, contributing to safer flight experiences.

GainSpan

Series B in 2007
GainSpan is a company that specializes in ultra-low-power Wi-Fi technology for sensors and embedded applications. Founded in 2006 by a team of engineers who previously worked at Intel Corporation, GainSpan aims to enhance the adoption of wireless sensor networks by addressing power consumption challenges associated with traditional Wi-Fi solutions. The company's innovative semiconductor and software offerings allow devices to operate for up to ten years on a single AA battery, leveraging existing Wi-Fi infrastructure. This technology facilitates the development of connected products for various applications, including temperature monitoring for energy management and condition monitoring of industrial equipment. GainSpan's integrated system-on-chip combines multiple components, such as a radio, media access controller, and applications processor, into one compact package, thereby streamlining the creation of smart home and city solutions.

Adapx

Series A in 2007
Adapx, Inc. is a technology company that specializes in user interface software solutions designed to enhance data capture and operational efficiency for businesses and government agencies. Its flagship product, Capturx, seamlessly converts natural speech, sketches, and handwriting into structured data, streamlining workflows and minimizing the need for manual data transcription. Capturx offers various applications, including integrations for Microsoft Office, SharePoint, and ArcGIS, along with mobile solutions for data collection. The company caters to diverse sectors, including manufacturing, defense, health, and utilities, and provides additional services such as mobile workflow analysis and design optimization. Founded in 1999 and based in Seattle, Washington, Adapx has established strategic partnerships with notable organizations like Microsoft and ESRI, enhancing its capabilities and reach in the market.

Fate Therapeutics

Series A in 2007
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing programmed cellular immunotherapies for cancer and immune disorders. The company specializes in NK- and T-cell immuno-oncology programs, with a diverse pipeline that includes candidates such as FT516 and FT596 for treating various hematologic malignancies, FT538 for acute myeloid leukemia and multiple myeloma, and FT500 for advanced solid tumors. Fate Therapeutics employs advanced techniques involving induced pluripotent stem cells (iPSCs) to create engineered product candidates, which are designed to be off-the-shelf solutions. The company has established strategic collaborations with notable partners, including Ono Pharmaceutical Co. Ltd. and Janssen Biotech, to enhance its research and development capabilities. Founded in 2007, Fate Therapeutics aims to leverage cutting-edge science to create innovative therapies that restore health by modulating the properties of stem cells.

M2E Power

Series A in 2007
M2E Power, founded in 2006 and based in Boise, Idaho, specializes in the development of innovative energy generation technology solutions aimed at providing clean power for mobile devices. The company creates batteries that utilize a micro generator capable of converting kinetic energy into electrical power, which is applicable in both military and consumer mobile devices. M2E Power's focus on energy generation technology positions it at the intersection of clean technology and mobile power solutions. In 2009, the company was acquired by Motionetics, further enhancing its capabilities and market reach.

Ambric

Series B in 2007
Ambric is a developer and manufacturer of software-programmable interface circuits that utilize a massively parallel processor array architecture. The company specializes in high-performance applications, particularly in media processing and medical imaging. Ambric's first generation chip architecture, known as the Am2045, integrates 336 processors on a single chip, providing a competitive alternative to large FPGAs, DSPs, and Intel x86 processors commonly used in embedded markets. The company's innovative parallel processor solution includes a structured object programming model, which facilitates effective programming for developers managing a large number of cores. Ambric has strategically targeted various sectors, including video compression, medical imaging, wireless base stations, and military applications.

Allozyne

Series B in 2007
Allozyne, Inc. is a biopharmaceutical company focused on developing novel protein therapeutic product candidates aimed at treating autoimmune and inflammatory diseases, as well as cancer. Founded in 2004 and headquartered in Seattle, Washington, Allozyne is known for its lead product candidate, AZ01, which is currently in Phase 1b clinical trials for relapsing-remitting multiple sclerosis. The company is also advancing AZ17, a bispecific antibody targeting various autoimmune and inflammatory conditions, including Crohn's disease and multiple sclerosis, and AZ05, an antibody-drug conjugate designed for treating solid tumors. Additionally, Allozyne specializes in the development of technologies that enhance the efficacy, safety, and dosing of protein-based therapeutics, including peptides and antibodies. The company operates as a subsidiary of Poniard Pharmaceuticals, Inc.

Accelerator Corp.

Series C in 2007
Accelerator Corporation, founded in 2003 and based in Seattle, Washington, is a venture capital firm that specializes in early-stage investments in biotechnology companies. The firm primarily invests up to $2 million in emerging growth and start-up ventures, focusing on identifying, evaluating, financing, and managing groundbreaking life sciences opportunities. Accelerator does not participate in subsequent financing rounds and typically maintains its investments for 12 to 24 months. The firm has developed a robust pipeline of deal flow through partnerships with top-tier investors and research institutions, providing access to state-of-the-art facilities and expertise in scientific and technical support. Over the past five years, Accelerator has invested in nine companies, three of which successfully raised follow-on financing exceeding $114 million. In total, Accelerator's portfolio companies have garnered over $143.5 million in initial and follow-on funding, supported by an additional commitment of $22.5 million from investors to further pursue innovative biotechnology opportunities. Through its unique resources and collaborations, Accelerator is positioned to streamline the development and commercialization of novel technologies in the biotechnology sector.

Verdezyne

Series C in 2007
Verdezyne is a private company specializing in synthetic biology, focusing on the production of chemicals from renewable sources. The company leverages its expertise in biological science and proprietary computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. Through this innovative approach, Verdezyne aims to optimize commercial fermentation processes, allowing for the creation of sustainable alternatives to petrochemicals. Its platform combines advanced biological techniques with proven manufacturing technologies, enabling the production of a wide range of chemical building blocks and additives used in everyday products. By reducing dependence on oil, Verdezyne provides cost-effective and environmentally friendly solutions in the chemical industry.

Serus

Series C in 2007
Serus Corporation specializes in intelligent operations management solutions tailored for enterprises that outsource their manufacturing processes. Founded in 2000 and based in Sunnyvale, California, the company provides a comprehensive suite of services designed to enhance business performance across various sectors, including semiconductor, consumer electronics, and original equipment manufacturing. Its offerings include transaction automation, operations planning, and business performance management solutions that facilitate the integration of business processes among trading partners. Key products encompass work-in-progress management for visibility and analysis, supply chain planning for modeling and material allocation, demand planning for forecasting, and purchase order management. Additionally, Serus provides fulfillment solutions, sales order management systems, and dashboard solutions for performance tracking. The company also supports its clients through subscription services, application hosting, trading partner management, and customer support, enabling effective collaboration and operational efficiency.

Action Engine

Series E in 2007
Action Engine is a software development, design, and data services agency that specializes in creating agile solutions to enhance business competitiveness through actionable intelligence. The company offers a browserless client/server platform, which serves as a foundational framework for developing and deploying application packs. These application packs facilitate intuitive and personalized access to content across various domains. Action Engine's key offerings include mobile advertising, mobile search, social networking, and mobile entertainment, positioning the company as a versatile provider in the technology landscape.

Virtugo Software

Venture Round in 2007
Virtugo Software provides software products that monitor, control, and optimize virtual and physical server environments. They deliver a workflow engine-based software platform that enables system integrators to automate system management processes for computing and communications environments. They provide the data necessary for performance monitoring, capacity management, resource optimization, and service metering.

NanoString Technologies

Series B in 2007
NanoString Technologies, Inc. is a life science company that specializes in providing innovative tools for translational research and molecular diagnostics globally. Founded in 2003 and headquartered in Seattle, Washington, the company developed a unique digital molecular barcoding technology for various applications in basic research and clinical diagnostics. Its flagship product, the nCounter Analysis System, consists of automated systems for sample preparation and data collection, allowing for the simultaneous profiling of numerous genes and proteins from single tissue samples. Additionally, NanoString offers the GeoMx Digital Spatial Profiler, which enhances spatial genomics research. The company also provides a range of services, including custom assay design, data analysis software, and molecular diagnostic test kits, such as Prosigna for breast cancer prognosis. Collaborations with major pharmaceutical companies and research institutions further bolster its position in advancing genomic and proteomic research.

Collaborative Software Initiative

Seed Round in 2007
Collaborative Software Initiative Inc. is a Portland, Oregon-based company founded in 2007 that focuses on developing and delivering enterprise software. It is known for its innovative collaborative approach, which engages community members, customers, and partners to form core teams for software development. This model allows Collaborative Software Initiative to create high-value products at reduced costs compared to traditional methods. One of its notable offerings is TriSano, a public health application designed for infectious disease surveillance, outbreak management, and bioterrorism response, serving a range of professionals, including epidemiologists and health officials. The company provides its software products under an open-source license or through annual subscriptions that include commercial support, prioritizing open standards and sustainability in its solutions.

AdmitOne Security

Series C in 2007
AdmitOne Security, headquartered in Issaquah, Washington, specializes in providing Software as a Service (SaaS) solutions focused on authentication and anti-fraud measures. The company's technology leverages the unique typing characteristics of computer users to verify and secure access to computer systems, ensuring robust protection against unauthorized entry.

Talyst

Series B in 2006
Talyst, founded in 2002, specializes in developing automated medication management systems aimed at enhancing patient safety across various healthcare environments. Initially focused on acute care hospital pharmacies, the company launched its flagship software platform, AutoPharm®, in 2003, which integrates medication storage, inventory management, ordering, barcoding, and clinical systems. Talyst's solutions are designed to improve workflow efficiency and patient safety not only in hospitals but also in long-term care facilities and correctional institutions, ensuring a comprehensive approach to medication management.

GenoLogics

Series B in 2006
GenoLogics, Inc. is a software development company that specializes in laboratory information management systems to enhance the diagnosis and treatment of diseases. Founded in 2002 and headquartered in Victoria, Canada, with an additional office in Redwood City, California, GenoLogics offers its BaseSpace Clarity LIMS, which supports research and clinical laboratories by tracking samples throughout the testing process. This platform facilitates improved accuracy, cost reduction, and quality maintenance. The company focuses on translational medicine and systems biology, providing solutions that enable integration across multiple laboratories and enhance biomedical research efforts. As of August 2015, GenoLogics operates as a subsidiary of Illumina Inc.

GainSpan

Series A in 2006
GainSpan is a company that specializes in ultra-low-power Wi-Fi technology for sensors and embedded applications. Founded in 2006 by a team of engineers who previously worked at Intel Corporation, GainSpan aims to enhance the adoption of wireless sensor networks by addressing power consumption challenges associated with traditional Wi-Fi solutions. The company's innovative semiconductor and software offerings allow devices to operate for up to ten years on a single AA battery, leveraging existing Wi-Fi infrastructure. This technology facilitates the development of connected products for various applications, including temperature monitoring for energy management and condition monitoring of industrial equipment. GainSpan's integrated system-on-chip combines multiple components, such as a radio, media access controller, and applications processor, into one compact package, thereby streamlining the creation of smart home and city solutions.

Virtugo Software

Series B in 2006
Virtugo Software provides software products that monitor, control, and optimize virtual and physical server environments. They deliver a workflow engine-based software platform that enables system integrators to automate system management processes for computing and communications environments. They provide the data necessary for performance monitoring, capacity management, resource optimization, and service metering.

TZero Technologies

Series B in 2006
TZero Technologies designs and develops ultra wideband semiconductors for video distribution. The company offers wirelessly connects devices and ultra wideband chipsets, which connect audiovisual components, such as televisions, set-top boxes, and digital video recorders. It serves consumer electronics, service providers, and computer manufacturers. The company was founded in 2003 and is headquartered in Sunnyvale, California.

VLST Corporation

Series B in 2006
VLST Corporation is a privately held biotechnology company that has developed a novel and streamlined approach to speed the development of effective therapeutics for the treatment of inflammatory and autoimmune diseases. The VLST platform uses novel bioinformatics and state-of-the-art proteomics, to identify viral genes whose protein products function as immunomodulatory agents. The resulting product candidates will be either human homologues to these virulence factors or monoclonal antibodies that mimic the function of the virulence gene products. This approach allows for the efficient identification of high quality, pre-validated drug targets for the treatment of autoimmune and inflammatory disorders. The Company's technology has identified potential product candidates for the treatment of disorders such as multiple sclerosis, lupus, psoriasis, rheumatoid arthritis and diabetes.

Applied Identity

Series B in 2006
Applied Identity, Inc. offers identity aware network security solutions. It offers ID-Audit, which displays real-time and historical user and resource activity; ID-Unify that enables the management of user identities between disparate identity stores; ID-Enforce, an identity aware network enforcement solution; and ID-Mark, which enables collection of audit data. The company also provides audit and compliance, asset protection, network level user and group separation, and identity virtualization solutions. Its clients include financial services, government department and agencies, technology innovators, and educational institutions.

Complete Genomics

Series A in 2006
Complete Genomics is a developer of advanced DNA sequencing technology focused on human genome sequencing and analysis. The company offers a comprehensive genomics analysis platform that integrates its proprietary sequencing technology with informatics and data management software. This combination allows Complete Genomics to deliver high-quality, affordable DNA sequencing services that facilitate large-scale research into the genetic mechanisms underlying drug responses and complex diseases. By providing ready-to-use genomic data, Complete Genomics aims to enhance the capabilities of researchers in the field of genomics and contribute to advancements in personalized medicine.

Allozyne

Series A in 2005
Allozyne, Inc. is a biopharmaceutical company focused on developing novel protein therapeutic product candidates aimed at treating autoimmune and inflammatory diseases, as well as cancer. Founded in 2004 and headquartered in Seattle, Washington, Allozyne is known for its lead product candidate, AZ01, which is currently in Phase 1b clinical trials for relapsing-remitting multiple sclerosis. The company is also advancing AZ17, a bispecific antibody targeting various autoimmune and inflammatory conditions, including Crohn's disease and multiple sclerosis, and AZ05, an antibody-drug conjugate designed for treating solid tumors. Additionally, Allozyne specializes in the development of technologies that enhance the efficacy, safety, and dosing of protein-based therapeutics, including peptides and antibodies. The company operates as a subsidiary of Poniard Pharmaceuticals, Inc.

Scout Analytics

Series B in 2005
Scout Analytics is a leader in digital revenue optimization, specializing in enhancing the average revenue per user for publishers by 10-15 percent. The company offers a cloud-based recurring revenue management platform that transforms usage data into predictive analytics, allowing publishers to effectively analyze subscription usage, spending, and trial conversions. Their SaaS application utilizes patent-pending behavioral analytics technology to target and monetize user engagement, making it a valuable tool for both subscription and advertising revenue models. With a presence in over 70 publishing organizations, Scout Analytics provides solutions to reduce customer churn, increase renewal revenue, optimize rate plan performance, and maximize trial conversions. Headquartered in Issaquah, Washington, Scout Analytics is a venture-backed company committed to driving revenue growth for its clients.

Translarity

Series A in 2005
Translarity, headquartered in Silicon Valley, specializes in innovative semiconductor wafer testing solutions, focusing on advanced probe card markets. The company pioneers full-wafer testing with low cost, high performance, and short cycle times. In 2017, Translarity acquired BucklingBeam to expand its offerings, now providing a comprehensive suite of probe card solutions including full probe cards and vertical probe head solutions. Leveraging its proprietary Space Translator™ technology, Translarity addresses the rapid evolution in probe technologies. Led by an experienced management team and supported by strong financial investors, Translarity has recruited top industry talent to develop Wafer Translator™ technology, resulting in a robust IP portfolio with over 45 issued patents and more than 50 filed.

AdmitOne Security

Series B in 2005
AdmitOne Security, headquartered in Issaquah, Washington, specializes in providing Software as a Service (SaaS) solutions focused on authentication and anti-fraud measures. The company's technology leverages the unique typing characteristics of computer users to verify and secure access to computer systems, ensuring robust protection against unauthorized entry.

Vantos

Series A in 2005
Vantos is a leading provider in the Enterprise Investigation Management market, offering comprehensive solutions for a range of workplace investigations, from minor misconduct to serious financial crimes. The company specializes in the automation and management of the investigation lifecycle through its flagship product, V-Flex. This platform includes analytics and visualization tools that help investigators identify trends and uncover root causes in data. Additionally, Vantos develops investigative playbooks that streamline the process for commonly occurring investigations, enabling organizations to effectively address their evolving investigation needs while minimizing costs.

Integrated Diagnostics

Series A in 2005
Integrated Diagnostics Inc. is a company focused on developing laboratory-based blood diagnostic tools that facilitate the early diagnosis of complex diseases through non-invasive blood tests. Established in 2005 and headquartered in Seattle, Washington, the company specializes in products that monitor multiple molecular markers simultaneously, offering valuable insights for conditions such as lung cancer. One of its key offerings is Xpresys Lung, a molecular blood test designed to provide objective information for assessing pulmonary nodules. Integrated Diagnostics is committed to leveraging advanced technologies to create a pipeline of innovative diagnostic products aimed at enhancing disease management for conditions including cancer, diabetes, and Alzheimer's. The company operates under a strategic partnership with Agilent Technologies Inc. and has been functioning as a subsidiary of Biodesix, Inc. since 2018.

NanoString Technologies

Series A in 2005
NanoString Technologies, Inc. is a life science company that specializes in providing innovative tools for translational research and molecular diagnostics globally. Founded in 2003 and headquartered in Seattle, Washington, the company developed a unique digital molecular barcoding technology for various applications in basic research and clinical diagnostics. Its flagship product, the nCounter Analysis System, consists of automated systems for sample preparation and data collection, allowing for the simultaneous profiling of numerous genes and proteins from single tissue samples. Additionally, NanoString offers the GeoMx Digital Spatial Profiler, which enhances spatial genomics research. The company also provides a range of services, including custom assay design, data analysis software, and molecular diagnostic test kits, such as Prosigna for breast cancer prognosis. Collaborations with major pharmaceutical companies and research institutions further bolster its position in advancing genomic and proteomic research.

Airgo Networks

Series E in 2005
Airgo Networks is a California-based company specializing in the development of multiple-input multiple-output wireless technology.

GenoLogics

Series A in 2005
GenoLogics, Inc. is a software development company that specializes in laboratory information management systems to enhance the diagnosis and treatment of diseases. Founded in 2002 and headquartered in Victoria, Canada, with an additional office in Redwood City, California, GenoLogics offers its BaseSpace Clarity LIMS, which supports research and clinical laboratories by tracking samples throughout the testing process. This platform facilitates improved accuracy, cost reduction, and quality maintenance. The company focuses on translational medicine and systems biology, providing solutions that enable integration across multiple laboratories and enhance biomedical research efforts. As of August 2015, GenoLogics operates as a subsidiary of Illumina Inc.

Safeharbor Knowledge Solutions

Venture Round in 2005
Safeharbor Knowledge Solutions is a provider of knowledge management solutions, specializing in forums and knowledge base software tools targeted at small and medium-sized businesses. Their flagship product, SmartSupport, is designed to enhance both internal and external knowledge management by allowing administrators to optimize content, streamline management processes, and improve return on investment for support channels. The platform enables businesses to quickly set up a knowledge base on their websites, facilitating customer inquiry deflection while delivering superior service. In addition to its knowledge base applications, Safeharbor offers expertise in creating rich content and a suite of contact center and help desk services to ensure comprehensive customer support. The company's focus on flexibility allows clients to effectively manage and enhance their content, thereby improving user engagement and operational efficiency.

Accelerator Corp.

Venture Round in 2004
Accelerator Corporation, founded in 2003 and based in Seattle, Washington, is a venture capital firm that specializes in early-stage investments in biotechnology companies. The firm primarily invests up to $2 million in emerging growth and start-up ventures, focusing on identifying, evaluating, financing, and managing groundbreaking life sciences opportunities. Accelerator does not participate in subsequent financing rounds and typically maintains its investments for 12 to 24 months. The firm has developed a robust pipeline of deal flow through partnerships with top-tier investors and research institutions, providing access to state-of-the-art facilities and expertise in scientific and technical support. Over the past five years, Accelerator has invested in nine companies, three of which successfully raised follow-on financing exceeding $114 million. In total, Accelerator's portfolio companies have garnered over $143.5 million in initial and follow-on funding, supported by an additional commitment of $22.5 million from investors to further pursue innovative biotechnology opportunities. Through its unique resources and collaborations, Accelerator is positioned to streamline the development and commercialization of novel technologies in the biotechnology sector.

Ambric

Series A in 2004
Ambric is a developer and manufacturer of software-programmable interface circuits that utilize a massively parallel processor array architecture. The company specializes in high-performance applications, particularly in media processing and medical imaging. Ambric's first generation chip architecture, known as the Am2045, integrates 336 processors on a single chip, providing a competitive alternative to large FPGAs, DSPs, and Intel x86 processors commonly used in embedded markets. The company's innovative parallel processor solution includes a structured object programming model, which facilitates effective programming for developers managing a large number of cores. Ambric has strategically targeted various sectors, including video compression, medical imaging, wireless base stations, and military applications.

Intelligent Results

Series B in 2004
Intelligent Results enables companies in financial services, utilities, telecom, government, and retail to manage their business more dynamically with a new standard in customer analytics and decision management. The Intelligent Results PREDIGYTM software platform allows companies to better understand and predict customer behavior and then quickly plan and operationalize targeted strategies. This empowers companies to improve the customer experience, allocate resources more effectively, and increase profitability. Intelligent Results’ approach, platform and applications result from 20 years experience that began in the national labs

Airgo Networks

Series D in 2004
Airgo Networks is a California-based company specializing in the development of multiple-input multiple-output wireless technology.

Intelligent Results

Series B in 2003
Intelligent Results enables companies in financial services, utilities, telecom, government, and retail to manage their business more dynamically with a new standard in customer analytics and decision management. The Intelligent Results PREDIGYTM software platform allows companies to better understand and predict customer behavior and then quickly plan and operationalize targeted strategies. This empowers companies to improve the customer experience, allocate resources more effectively, and increase profitability. Intelligent Results’ approach, platform and applications result from 20 years experience that began in the national labs

Airgo Networks

Series C in 2003
Airgo Networks is a California-based company specializing in the development of multiple-input multiple-output wireless technology.

Entomo

Series C in 2003
Entomo, Inc. specializes in providing cloud-based Channel Control and Revenue Management solutions aimed at helping businesses navigate the complexities of distribution channels. Their integrated software platform includes applications for data aggregation, channel incentive management, commission splits, and inventory price protection. By offering enhanced visibility and control over channel operations, Entomo enables organizations to automate workflows, simplify processes, and foster better collaboration with partners. This ultimately supports revenue growth while reducing costs and ensuring compliance across the channel ecosystem.

Max-Viz

Venture Round in 2002
Max-Viz is a specialized company focused exclusively on the design, development, and manufacturing of Enhanced Vision Systems for the aviation industry. It is the only organization dedicated to this niche, creating advanced infrared vision systems that enable aircraft operators to see clearly in challenging conditions such as fog, haze, smoke, and darkness. The company is driven by a team of passionate and experienced scientists and engineers, all committed to enhancing safety for both civilian and military aviation. Through its innovative technology, Max-Viz aims to improve visibility and operational efficiency, contributing to safer flight experiences.

Safeharbor Knowledge Solutions

Venture Round in 2002
Safeharbor Knowledge Solutions is a provider of knowledge management solutions, specializing in forums and knowledge base software tools targeted at small and medium-sized businesses. Their flagship product, SmartSupport, is designed to enhance both internal and external knowledge management by allowing administrators to optimize content, streamline management processes, and improve return on investment for support channels. The platform enables businesses to quickly set up a knowledge base on their websites, facilitating customer inquiry deflection while delivering superior service. In addition to its knowledge base applications, Safeharbor offers expertise in creating rich content and a suite of contact center and help desk services to ensure comprehensive customer support. The company's focus on flexibility allows clients to effectively manage and enhance their content, thereby improving user engagement and operational efficiency.

Action Engine

Series B in 2002
Action Engine is a software development, design, and data services agency that specializes in creating agile solutions to enhance business competitiveness through actionable intelligence. The company offers a browserless client/server platform, which serves as a foundational framework for developing and deploying application packs. These application packs facilitate intuitive and personalized access to content across various domains. Action Engine's key offerings include mobile advertising, mobile search, social networking, and mobile entertainment, positioning the company as a versatile provider in the technology landscape.

Intelligent Results

Series A in 2002
Intelligent Results enables companies in financial services, utilities, telecom, government, and retail to manage their business more dynamically with a new standard in customer analytics and decision management. The Intelligent Results PREDIGYTM software platform allows companies to better understand and predict customer behavior and then quickly plan and operationalize targeted strategies. This empowers companies to improve the customer experience, allocate resources more effectively, and increase profitability. Intelligent Results’ approach, platform and applications result from 20 years experience that began in the national labs
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.